National Health Investors (NHI) Capital Expenditures (2009 - 2026)

National Health Investors has reported Capital Expenditures for 18 years, with the latest figure at $105.5 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 41.63% year-over-year to $105.5 million; the trailing twelve-month figure through Mar 2026 stood at $305.1 million (up 43.49% YoY), and the FY2025 full-year result was $274.1 million, up 98.42% from the prior year.
• Capital Expenditures for Q1 2026 stood at $105.5 million, down from $143.1 million in the prior quarter.
• The five-year high for Capital Expenditures was $143.1 million in Q4 2025, with the low at -$4.3 million in Q3 2022.
• Historically, Capital Expenditures has averaged $46.3 million across 5 years, with a median of $23.2 million in 2023.
• The largest YoY upside for Capital Expenditures was 8607.14% in 2022 against a maximum downside of 109.3% in 2022.
• National Health Investors' Capital Expenditures stood at -$528000.0 in 2022, then soared by 7034.47% to $36.6 million in 2023, then surged by 250.31% to $128.3 million in 2024, then increased by 11.56% to $143.1 million in 2025, then declined by 26.28% to $105.5 million in 2026.
• The last three Capital Expenditures figures came in at $105.5 million (Q1 2026), $143.1 million (Q4 2025), and $56.5 million (Q2 2025), per Business Quant data.